Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schett

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Clinical Biochemistry|March 3, 2012
MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitisS S Veidal, D V Larsen, X Chen, et al.
Cell Death and Differentiation|March 5, 2016
A blast without power - cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responsesC Maueröder, R A Chaurio, T Dumych, et al.
Arthritis and Rheumatism|March 7, 2001
Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alphaK Redlich, H P Kiener, G Schett, et al.
Transplantation and Cellular Therapy|October 14, 2022
Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus ErythematosusS Kretschmann, S Völkl, H Reimann, et al.
Lupus|May 29, 2012
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndromeC Janko, S André, L E Munoz, et al.
Plos One|December 24, 2014
No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritisD Kienhöfer, J Hahn, I Schubert, et al.
Contemporary Clinical Trials Communications|May 27, 2021
Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled studyH M Schenker, K Tascilar, L Konerth, et al.
Clinical and Experimental Rheumatology|February 21, 2012
Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitisH Skjøt-Arkil, G Schett, C Zhang, et al.
Cell Death and Differentiation|February 27, 2016
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancerR B Birge, S Boeltz, S Kumar, et al.
Zeitschrift Fur Rheumatologie|April 26, 2018
[New insights into the function of bone marrow]G Schett, A Bozec, I Bekeredjian-Ding, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Clinical Biochemistry|March 3, 2012
MMP mediated type V collagen degradation (C5M) is elevated in ankylosing spondylitisS S Veidal, D V Larsen, X Chen, et al.
Cell Death and Differentiation|March 5, 2016
A blast without power - cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responsesC Maueröder, R A Chaurio, T Dumych, et al.
Arthritis and Rheumatism|March 7, 2001
Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alphaK Redlich, H P Kiener, G Schett, et al.
Transplantation and Cellular Therapy|October 14, 2022
Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus ErythematosusS Kretschmann, S Völkl, H Reimann, et al.
Lupus|May 29, 2012
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndromeC Janko, S André, L E Munoz, et al.
Plos One|December 24, 2014
No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritisD Kienhöfer, J Hahn, I Schubert, et al.
Contemporary Clinical Trials Communications|May 27, 2021
Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain - Study protocol for a randomized double-blind controlled studyH M Schenker, K Tascilar, L Konerth, et al.
Clinical and Experimental Rheumatology|February 21, 2012
Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitisH Skjøt-Arkil, G Schett, C Zhang, et al.
Cell Death and Differentiation|February 27, 2016
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancerR B Birge, S Boeltz, S Kumar, et al.
Zeitschrift Fur Rheumatologie|April 26, 2018
[New insights into the function of bone marrow]G Schett, A Bozec, I Bekeredjian-Ding, et al.
Pageof 12